| Bioactivity | S1b3inL1 is a SARS-CoV-2 spike protein macrocyclic peptide inhibitor. S1b3inL1 can bind the conserved site of spike protein with high affinity and inhibit the infection of various SARS-CoV-2 variant strains. S1b3inL1 has antiviral activity[1]. |
| CAS | 3027437-21-1 |
| Sequence | cyclo(Ac-Tyr-Arg-Arg-Pro-Arg-Glu-Gln-Ile-Ile-Ile-Gly-Ser-Leu-Trp-Val-Phe-Cys)-Gly-NH2 |
| Shortening | cyclo(Ac-YRRPREQIIIGSLWVFC)G-NH2 |
| Formula | C103H158N30O24S |
| Molar Mass | 2232.61 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Thijssen V, et al. A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein. Proc Natl Acad Sci U S A. 2023 Jun 27;120(26):e2303292120. |
S1b3inL1
CAS: 3027437-21-1 F: C103H158N30O24S W: 2232.61
S1b3inL1 is a SARS-CoV-2 spike protein macrocyclic peptide inhibitor. S1b3inL1 can bind the conserved site of spike prot
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.